HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.

AbstractBACKGROUND AND PURPOSE:
Antidepressants are a first-line treatment against neuropathic pain. We previously demonstrated that beta(2)-adrenoceptors are necessary for antidepressants to exert their anti-allodynic action. The aim of the present study was to assess whether beta(2)-adrenoceptor agonists could be sufficient to alleviate neuropathic allodynia.
EXPERIMENTAL APPROACH:
We used a murine model of neuropathy induced by unilateral sciatic nerve cuffing in C57BL/6J mice. We previously demonstrated that this animal model is sensitive to chronic, but not to acute, treatment with antidepressant drugs, which is clinically relevant. The mechanical allodynia was evaluated using the von Frey filaments.
KEY RESULTS:
We showed that chronic but not acute treatment with the beta-adrenoceptor agonists, bambuterol, isoprenaline, fenoterol, salbutamol, salmeterol, terbutaline or ritodrine suppressed mechanical allodynia. We confirmed that the action of these beta-adrenoceptor agonists was mediated through beta(2)-adrenoceptors by blocking it with intraperitoneal or intrathecal, but not intracerebroventricular or intraplantar, injections of the antagonist ICI118551. We also showed that chronic treatments with the beta-adrenoceptor antagonists, propranolol or ICI118551 did not suppress the allodynia.
CONCLUSIONS AND IMPLICATIONS:
Our data show that chronic treatment with beta-adrenoceptor agonists has the same antiallodynic properties as treatments with antidepressant drugs. This study was, however, conducted in an animal model, and a clinical validation will be required to confirm the value of the present findings in patients.
AuthorsNada Choucair-Jaafar, Ipek Yalcin, Jean-Luc Rodeau, Elisabeth Waltisperger, Marie-José Freund-Mercier, Michel Barrot
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 158 Issue 7 Pg. 1683-94 (Dec 2009) ISSN: 1476-5381 [Electronic] England
PMID19912227 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Propanolamines
  • ICI 118551
  • Propranolol
Topics
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists (administration & dosage, pharmacology)
  • Adrenergic beta-Antagonists (administration & dosage, pharmacology)
  • Animals
  • Disease Models, Animal
  • Drug Administration Schedule
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuralgia (drug therapy)
  • Pain Measurement
  • Propanolamines (administration & dosage, pharmacology)
  • Propranolol (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: